Multimodal keloid therapy with excision, application of mitomycin C, and radiotherapy

Dermatologic Surgery

Volumn 40, Issue 4, 2014, Pages 480-482

  Willett, Matthew ^a   Handfield, Kent ^a   Marquart, Jason ^a  

^a WALTER REED ARMY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MITOMYCIN; SILICONE; TRIAMCINOLONE;

ADULT; ADVERSE DRUG REACTION; AFRICAN AMERICAN; CASE REPORT; CLINICAL EFFECTIVENESS; DERMATITIS; EXCISION; FEMALE; FOLLOW UP; HUMAN; KELOID; LETTER; MALE; OUTPATIENT; PATIENT SATISFACTION; POSTOPERATIVE CARE; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; RADIATION DOSE FRACTIONATION; RADIOTHERAPY; WOUND CARE;

ADULT; ANTIBIOTICS, ANTINEOPLASTIC; CHEMORADIOTHERAPY, ADJUVANT; DOSE FRACTIONATION; FEMALE; HUMANS; KELOID; MALE; MITOMYCIN; PATIENT SATISFACTION;

EID: 84897999032     PISSN: 10760512     EISSN: 15244725     Source Type: Journal    
DOI: 10.1111/dsu.12423     Document Type: Letter

References (5)

1. Naylor M, Brissett A,. Current concepts in the etiology and treatment of keloids. Facial Plast Surg 2012; 28: 504-12.
2. Sidle D, Kim H,. Keloids: prevention and management. Facial Plast Surg Clin North Am 2011; 19: 505-15.
3. Kal H, Veen R,. Biologically effective doses of postoperative radiotherapy in the prevention of keloids. Strahlenther Onkol 2005; 181: 717-23.
4. Shridharani SM, Magarakis M, Manson PN, Singh NK, et al. The emerging role of antineoplastic agents in the treatment of keloids and hypertrophic scars. Ann Plast Surg 2010; 64: 355-61.
5. Gupta M, Narang T,. Role of mitomycin C in reducing keloid recurrence: patient series and literature review. J Laryngol Otol 2011; 125: 297-300.